As of Apr 25
| -0.0353 / -3.73%|
The 2 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 9.30, with a high estimate of 12.00 and a low estimate of 6.60. The median estimate represents a +921.98% increase from the last price of 0.91.
The current consensus among 2 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.